The U.S. Food and Drug Administration (FDA) announced in May 2026 that it would be easing restrictions on unauthorized nicotine products, including flavored nicotine pouches and e-cigarettes. This represents a significant change from its previous policy, which required companies to undergo lengthy, rigorous reviews before they were available in the market.
Few industries experience as much regulatory scrutiny as tobacco, which is why the World Health Organization’s Framework Convention on Tobacco Control (WHO FCTC) is known for being one of the most embraced in the whole of the United Nations. COP11 provided an opportunity for entities across the globe to meet and discuss this framework.
This is a topic worth following for any nicotine pouch users hoping to be on top of what’s happening in the legislative world, and this guide runs through the main topics discussed at the conference. They include environmental sustainability, marketing, and how new nicotine pouches should be treated.
Those interested may also enjoy reading our takeaways from the Global Tobacco & Nicotine Forum 2025.
On January 1, 2026, a new wave of nicotine product regulations came into effect across the United States. Since then, lawmakers have continued introducing new restrictions on nicotine pouches and other smoke-free products, with proposals ranging from flavor bans and tax increases to sales and shipping restrictions.
Because nicotine pouch regulations can vary significantly between states—and are often subject to change—staying informed isn't always easy. That's why we've created this regularly updated guide, tracking the latest federal and state-level developments that may affect nicotine pouch users across the country.
The more popular nicotine pouches become, the more responsible both manufacturers and users must be. One area that has been increasingly receiving attention is the packaging manufacturers use, as this impacts how easily children can open pouch cans. The FDA has urged manufacturers to take measures to reduce the probability of this happening, and it’s likely to continue to be a relevant topic.
This article breaks down the meaning of the announcement, possible directions that future legislation can take, and the role users themselves can play in protecting public health.
The fast growth of the nicotine pouch market has led to a regulation crisis, with brands entering the market and seeking approval faster than the U.S. Food and Drug Administration (FDA) can decide whether to authorize them.
Pouch users might typically care more about getting their hands on their product of choice than understanding the complex regulations behind them. But with recent developments, like the pilot program to fast-track pouch approval, it's natural to have a little curiosity.
This article runs through the basics of nicotine pouch regulation, including the difference between PMTAs and MGOs.
With the regulatory landscape changing so fast in the nicotine pouch world, it’s more important than ever for major players to learn from each other. The Trump Administration and state governments are continuing to make significant changes to nicotine legislation, many of which we outlined in our regulatory roundup 2025. Across the world, other countries are experiencing the same.
The Global Tobacco & Nicotine Forum exists so discussions about these kinds of regulations can take place, and the latest event took place in October 2025. This article summarizes the main themes and takeaways in relation to nicotine pouches, which have relevance for brands, retailers, and consumers alike.
Nothing strikes fear into the heart of nicotine pouch manufacturers quite like hearing there’s been a change in regulations. When it comes to tax hikes, this news can also be a source of terror for users. But here in the US, these changes have become unescapable. 2025 has been a year with plenty of change, and it can be hard to keep up — but Prilla has everyone covered.
In September 2025, the U.S. Food and Drug Administration (FDA) announced a pilot program to streamline the review of nicotine pouches. This move comes after the Trump administration put pressure on the FDA to make the authorization process more efficient; currently, companies have to wait years for an authorization or rejection. In contrast, the pilot program aims to authorize the nicotine pouches participating by December 2025 (according to reporting from Reuters).
The pouches that will be part of the process are ZYN Ultra from Philip Morris International, On! And On! Plus from Altria, VELO Mini from Reynolds American, and FRE and ALP from Turning Point Brands.
The ongoing ZYN shortage is proof that a company can be a victim of its own success. Demand for the brand’s pouches has steadily increased over the last few years, and since May 2024, many US states have been struggling to replenish their stock levels — especially for the most popular flavors.
This post will shed some light on the situation and offers suggestions for obtaining ZYN pouches (or a suitable alternative).
